What Is a Schedule 13D Filing? A Plain-English Guide With Live Examples
Executive summary. A Schedule 13D filing is the SEC form an investor must file within 5 business days of acquiring more than 5% of a public company's voting stock with control intent. It names the filer, the issuer, the purpose, and the share count. Since February 5, 2024, the deadline is 5 business days, down from 10. Amendments (13D/A) are due within 2 business days.
A Schedule 13D filing tells you, in roughly six pages, that someone has crossed the 5% ownership threshold of a public company and intends to do something about it. That "something" is the entire reason the form exists. The Williams Act of 1968 added Section 13(d) to the Securities Exchange Act of 1934 because Congress had decided that markets, in the words of the SEC's own staff, should not let large blocks of stock change hands in silence.
This is the plain-English guide. It is built for hedge fund analysts, RIA principals, and family-office allocators who need to know what a 13D is, what it isn't, and what changed in 2024. Live filings appear at the end, refreshed from the SEC.
What a Schedule 13D filing actually is
The statutory hook is Section 13(d) of the Securities Exchange Act of 1934, added by the Williams Act of 1968. Any person who, after acquiring beneficial ownership of an equity security registered under Section 12, becomes the beneficial owner of more than 5% of that class must file a statement with the SEC. The original 1968 threshold was 10%; Congress lowered it to 5% in 1970 because even small blocks confer real influence.
Two key concepts. First, "beneficial ownership" is broader than legal title — it captures voting power and disposition power, including derivatives that give the holder economic exposure. Second, the form is reserved for control intent. An investor without control intent files Schedule 13G, a lighter form. The SEC's October 2023 release puts it directly: "An investor with control intent files Schedule 13D, while Exempt Investors and investors without a control intent, such as Qualified Institutional Investors and Passive Investors, file Schedule 13G."
The form contains seven items. Item 1 names the security and issuer. Item 2 identifies the filer. Item 3 sources the funds. Item 4 is the field everyone reads first: Purpose of Transaction. It is where Elliott Management, Starboard, Trian, and the rest signal whether this is a passive accumulation or a campaign for a board seat, a sale, a spin-off, or a leveraged recap. Item 5 reports the share count and ownership percentage. Item 6 discloses arrangements with other holders. Item 7 lists exhibits — the Investor.gov glossary entry is the cleanest official summary.
A Schedule 13D filing is not, on its own, a buy signal. Most initial 13Ds are filed by founders, insiders converting to public ownership, or strategic acquirers — not by activists. The activist subset is what 13D Monitor's Ken Squire estimates at roughly 2,000 13D filings and 4,000 13D amendments per year (13D Monitor, About Us). The colloquial use of "13D" to mean "activist coming for the board" is shorthand. It is wrong about half the time.
What changed in 2024 — the new 5-business-day deadline
For 56 years, the Williams Act gave investors 10 calendar days to file a Schedule 13D. That changed.
On October 10, 2023, the SEC adopted final amendments to Rule 13d-1. From the press release:
"[T]oday's amendments: shorten the deadline for initial Schedule 13D filings from 10 days to five business days and require that Schedule 13D amendments be filed within two business days; generally accelerate the filing deadlines for Schedule 13G beneficial ownership reports..."
The 13D piece took effect February 5, 2024. The 13G changes took effect September 30, 2024. Compliance with the new structured-data (XML) requirement for 13D and 13G followed on December 18, 2024. By 2026, every new beneficial-ownership filing on EDGAR is machine-readable.
The chair at the time, Gary Gensler, framed the change in the same release: "In our fast-paced markets, it shouldn't take 10 days for the public to learn about an attempt to change or influence control of a public company." The compromise — 5 business days, not T+1 — was a concession to filers' compliance burden. Some commentators wanted faster.
For an analyst on the buy side, the practical effect of the Schedule 13D filing deadline change is that the window for a stale-data information edge has narrowed from roughly 14 calendar days to roughly 7. Amendments now arrive within 2 business days, which means a campaign letter, a poison-pill response, or a stake-up disclosure hits public tape inside a single trading week.
Schedule 13D filing vs 13G vs 13D/A vs 13G/A
The four forms are easy to confuse and routinely mislabeled in headlines.
| Form | Filer | Trigger | Initial deadline | Activist signal? |
|---|---|---|---|---|
| Schedule 13D | Investor with control intent | Crosses 5% | 5 business days | High — Item 4 is the headline |
| Schedule 13D/A | Same filer | Material change to a prior 13D | 2 business days | High — most news lives in amendments |
| Schedule 13G | Qualified Institutional Investor or Passive Investor | Crosses 5% with no control intent | QII: 45 days after quarter-end or 5 business days after >10%. Passive: 5 business days | Low — by definition, no control intent |
| Schedule 13G/A | Same filer | Various, per Reg 13D-G | Per filer category | Low |
Source: SEC Press Release 2023-219; Investor.gov.
A 13G filed by Vanguard or BlackRock is a passive disclosure. A 13D filed by Elliott Management is a campaign opening. The same 5% threshold; very different signal. The distinction matters when an analyst reads a screen: a 13D on a small-cap target with light insider buying is a different setup than a 13G on the same name.
The amendment-versus-initial split also matters. In the 13dwatch live feed window covering 2026-04-02 through 2026-04-28, 22 of the 60 most recent activist filings were initial Schedule 13D filings; 38 were Schedule 13D/A amendments. Activism is mostly amendment traffic. The first filing announces the position; the next several announce the campaign.
How to read Item 4 — the purpose section
Item 4 is the field that earns the 13D its activist reputation. The legal text invites the filer to describe "the purpose or purposes of the acquisition" and any plans relating to extraordinary corporate transactions, sale of assets, changes to the board, capital structure, or charter amendments.
In practice, Item 4 disclosures fall into a small number of patterns: "for investment purposes" (boilerplate, often a placeholder), "intends to engage in discussions with the board," "will seek to maximize value through" (the polite preamble to a campaign), and outright tender-offer or proxy-contest language. Roughly half of all initial 13D Item 4 sections are formulaic. The signal lives in the qualifications, the exhibits attached under Item 7 (open letters, presentations), and in the speed and cadence of subsequent 13D/A amendments.
A complete decoding of Item 4 patterns is beyond this guide and is the subject of a follow-up post; for now, the rule of thumb is: read the exhibits before the boilerplate.
Live Schedule 13D filings — the 5 most recent on the SEC tape
The widget below pulls directly from the 13dwatch live feed, which mirrors the SEC EDGAR new-filing stream. It refreshes every 5 minutes. The 5 most recent initial Schedule 13D filings, as of the most recent server snapshot, appear here. No subscription required.
Caption: Live Schedule 13D filings, pulled from the 13dwatch feed of the SEC EDGAR new-filings stream. Snapshot taken 2026-04-30.
For reference, the snapshot taken at 2026-04-30T06:10:45Z showed:
| Filed | Filer | Issuer | Ticker | Shares |
|---|---|---|---|---|
| 2026-04-28 | Rai Cheddi Bharrat | Visium Technologies, Inc. | VISM | 146,444,342 |
| 2026-04-28 | Lazar David E. | MAINZ BIOMED N.V. | QUCY | 477,000,000 |
| 2026-04-27 | Feldman Jesse | Electro-Sensors, Inc. | ELSE | 1,939,258 |
| 2026-04-27 | venBio Global Strategic Fund V, L.P. | ACHIEVE LIFE SCIENCES, INC. | ACHV | 10,737,317 |
| 2026-04-27 | Emerald Bioventures, LLC | Galera Therapeutics, Inc. | GRTX | 40,216,160 |
Each Filing link resolves to the raw SGML document on sec.gov/Archives. A direct read of accession 0001193125-26-173780 (an Illumina-affiliated initial 13D on Alamar Biosciences from the same window) confirms FORM TYPE: SCHEDULE 13D, filed 2026-04-23 under the 1934 Act.
Note the composition. None of the five most recent initial 13D filings comes from a household-name activist. Two are individual filers (Bharrat, Lazar, Feldman); three are venture and life-sciences funds. This is normal. Initial 13D traffic skews toward founders, biotech anchor investors, and special-situation strategics. The Elliotts and Starboards of the world show up in the 13D/A amendment count instead, which is why a serious workflow watches both lanes.
Where Schedule 13D filings sit in a serious analyst's workflow
A 13D in isolation answers the question, "who crossed 5%?" It does not answer, "is anything else going on?" The latter is the question that determines whether the filing is tradeable.
Three cross-references separate signal from noise.
Form 4 insider activity. A 13D landing on a name where the CEO and two directors have bought stock in the prior 30 days is a categorically different setup than a 13D landing on a name where insiders have been selling. The 13dwatch live feed joins each 13D to the trailing 90 days of Form 4 transactions for the same issuer. Out of the 60 most recent filings in the public window, 9 had matching Form 4 activity from corporate insiders.
Institutional consensus. A 13D where 5 of the 10 elite portfolio managers tracked by 13dwatch — Berkshire, Pershing Square, Baupost, Appaloosa, Third Point, Duquesne, Viking, Tiger Global, Greenlight, Lone Pine — are also long is corroboration. A 13D where none of them are is an idiosyncratic call. The feed tags this in the institutional_consensus field.
FINRA short interest. Activist filings that land on names with elevated days-to-cover are the classic squeeze setup. The 13dwatch feed joins each 13D to the most recent FINRA settlement-date short-interest record. In the live window, 53 of 60 filings had a matching short-interest record.
These three joins are the reason 13dwatch exists. The SEC publishes 13D, Form 4, and 13F as separate streams. FINRA publishes short interest in a fourth stream. None of them join cleanly without a CIK-and-CUSIP normalization layer. Building one once is worth more than reading any individual 13D.
What this means for hedge funds and RIAs
For an emerging hedge fund manager under $500M AUM, the Schedule 13D filing tape is a free idea-generation feed that institutional prime brokers used to gatekeep behind soft-dollar relationships. Three operational notes.
The window is now 5 business days, not 10. Workflows built on the old 10-day calendar deadline are leaving 3-4 trading days of edge on the table. Update your alerts.
Watch amendments more than initials. The 60-filing window above is 63% amendments. Initials disclose existence; amendments disclose intent.
Treat the colloquial "activist 13D" as a subset. Elliott, Starboard, Trian, Icahn, Engaged Capital, and Land & Buildings together account for a small fraction of the 13D volume in any given week. The rest is founders, biotech anchors, and corporate strategics. Filter accordingly.
For RIAs and family offices managing concentrated equity portfolios, the relevant question is the inverse: a 13D on a portfolio holding is a forced-research event. Read it the day it lands. The same filing that signals activism to a long-only manager signals tax-and-vote planning to a wealth advisor.
A note on what 13dwatch is, and isn't. We are a B2B intelligence service that publishes a live, joined feed of activist 13D and 13G filings, Form 4 insider transactions, institutional consensus across the 10 elite managers above, and FINRA short interest. We do not publish investment advice. We do not paywall the historical data tables. We paywall the live feed, the multi-source clustering, and the analyst briefs. The plain-English explainer you are reading is free for the same reason 13D Monitor's (13dmonitor.com) and WhaleWisdom's (whalewisdom.com/schedule13d) explainers are free: education brings the right readers.
See the live feed of every Schedule 13D and 13G filing on 13dwatch.com.
Methodology and sources. Filing-deadline rules: SEC Press Release 2023-219, October 10, 2023. Statutory authority: Section 13(d) of the Securities Exchange Act of 1934, added by the Williams Act of 1968. Form taxonomy: Investor.gov, Schedules 13D and 13G and the SEC staff Compliance and Disclosure Interpretations on Sections 13(d) and 13(g). Live filing data: 13dwatch.com/api/feed, snapshot 2026-04-30T06:10:45Z, joined to FINRA short-interest settlement-date 2026-03-31. Direct accession verification of 0001193125-26-173780 (Illumina/Alamar) performed 2026-04-30 against sec.gov/Archives/edgar/data/2104204/0001193125-26-173780.txt. This article is research, not investment advice. Long Street Consulting LLC.